Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

9.560 -5.250 (-35.45%)

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Alteryx, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

September 18, 2023

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session. Newegg Commerce, Inc. (NASDAQ: NEGG) shares climbed 8.7% to...

Via Benzinga

Why Iovance Biotherapeutics Stock Rocketed 13% Higher Today ↗

September 15, 2023

The approval process for the biotech's most advanced pipeline drug program is going quite well, it seems.

Via The Motley Fool

Personalized Skin Cancer Therapy, Despite FDA Delay: Analysts Show Confidence In Iovance Biotherapeutics Therapy ↗

September 15, 2023

Thursday, the FDA extended the review period for Iovance Biotherapeutics Inc's (NASDAQ: IOVA) marketing application seeking accelerated approval for lifileucel

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 15, 2023

Via Benzinga

Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

September 15, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.

Via Benzinga

Nasdaq Down Over 1%; US Industrial Output Rises In August ↗

September 15, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% points on Friday. The Dow traded down 0.52% to 34,727.05 while the NASDAQ fell 1.31% to 13,743.78. The...

Via Benzinga

Topics Stocks

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) is One of Friday Morning’s Most Active Stocks

September 15, 2023

Via Investor Brand Network

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 15, 2023

Via Benzinga

Why Volcon Shares Are Trading Lower By 19%; Here Are 20 Stocks Moving Premarket ↗

September 15, 2023

Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares rose 38.7% to $0.1421 in pre-market trading after gaining 10% on Thursday.

Via Benzinga

Where Iovance Biotherapeutics Stands With Analysts ↗

September 13, 2023

Via Benzinga

Expert Ratings for Iovance Biotherapeutics ↗

August 09, 2023

Via Benzinga

Mitek Systems, Arm Holdings And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗

September 15, 2023

U.S. stock futures traded mostly higher this morning on Friday. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

U.S. Food and Drug Administration Updates Prescription Drug User Fee Act (PDUFA) Action Date for Lifileucel for the Treatment of Advanced Melanoma

September 14, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Why Shares of Iovance Biotherapeutics Dropped Thursday ↗

September 14, 2023

The biotech stock's lead therapy is looking at some competition.

Via The Motley Fool

Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 14, 2023

Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi.

Via Benzinga

Iovance Biotherapeutics Stock Is Down 15%: What's Going On? ↗

September 14, 2023

Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading lower by 15.8% to $4.58, despite a lack of company-specific news for the session.

Via Benzinga

Iovance Biotherapeutics to Present at 2023 Wells Fargo Healthcare Conference

September 07, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List ↗

August 28, 2023

Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook.

Via InvestorPlace

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

August 18, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Reports Second Quarter and First Half 2023 Financial Results and Corporate Updates

August 08, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Cathie Wood Continues Iridium Shopping Spree — Ark Invest Buys $3.6M Worth Of Satellite Company's Stock ↗

August 02, 2023

Via Benzinga

Cathie Wood Buys $3.4M Worth Of Shares In This Payments Software Firm — Also Increases Exposure To Iridium Stock ↗

August 01, 2023

Via Benzinga

Cathie Wood's Ark Invest Sells Robinhood, Coinbase Shares — Buys $3.5M Worth Of Stock Of This Social Media Company ↗

July 31, 2023

Via Benzinga

7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick ↗

July 31, 2023

For investors who choose wisely, profits in healthcare stocks can be spectacular. But the losses can also be dramatic if you choose poorly.

Via InvestorPlace

Cathie Wood's Ark Invest Continues To Sell Shares Of Warren Buffett-Backed BYD — Coinbase Holdings Trimmed As Well ↗

July 26, 2023

Via Benzinga

Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy at IASLC 2023 World Conference on Lung Cancer

July 25, 2023

Oral Presentation of Cohort 3A Data from IOV-COM-202 Phase 2 Clinical Trial of LN-145 in Combination with Pembrolizumab in Anti-PD1-naïve Advanced (metastatic or unresectable) Non-Small Cell Lung...

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics to Host Second Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, August 8, 2023

July 24, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

July 21, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Announces Closing of $172.5 Million Common Stock Public Offering

July 13, 2023

Offering Includes Exercise in Full of the Underwriters’ Option to Purchase an Additional 3 Million Shares of Common Stock

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 11, 2023

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.

Via Benzinga

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.